HER2-POSITIVE

Clinical trials for HER2-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2-POSITIVE trials appear

Sign up with your email to follow new studies for HER2-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug targets Hard-to-Treat HER2 cancers in early trial

Disease control Ongoing

This early-stage study tests an experimental drug called BL-M17D1 in 120 adults with advanced solid tumors that have a specific protein (HER2) or a HER2 gene change. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. Participants mus…

Matched conditions: HER2-POSITIVE

Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control

Last updated May 16, 2026 23:47 UTC

HER2-POSITIVE

Get alerted when new HER2-POSITIVE trials appear

New drug targets Hard-to-Treat HER2 cancers in early trial